Association between admission blood urea nitrogen and clinical outcomes in patients with large ischemic stroke undergoing endovascular treatment.

Authors

Mingrui Zhou, Haisong Feng, Shuangzhi Wang, Kaiyuan Feng, Linyu Li, Lilan Wang, Haoxuan Zhu, Gaoming Li, Chunye Chen, Mingyang Chen, Yuhan Fan, Qiuyi Yang, Yihui Yang, Yian Chen, Binghan Wang, Guanting Heng, Xuexiao Zhao, Chawen Ding, Jiaxing Song, Miao Chai, Jie Pu

Published in

Frontiers in neurology. Volume 17. Pages 1880623. Epub Sep 23, 2026.

Abstract

This study aimed to investigate the association between admission blood urea nitrogen (BUN) and clinical outcomes in patients with large ischemic stroke undergoing endovascular treatment (EVT).
This study was a subgroup analysis of a prospective, multicenter cohort study. 472 patients with large ischemic stroke undergoing EVT from the original database were included. Patients were stratified into three groups based on admission BUN levels. The primary effectiveness outcome was modified Rankin Scale (mRS) score 0-3 at 90 days. Safety outcomes included 90-day mortality and symptomatic intracranial hemorrhage (sICH) within 48 h.
A total of 472 patients were included and stratified into three groups: Tertile 1 group (≤5.00 mmol/L), Tertile 2 group (5.01-6.80 mmol/L), and Tertile 3 group (>6.80 mmol/L). Compared with patients in BUN Tertile 1 group, patients in BUN Tertile 3 had significantly lower odds of achieving a favorable outcome (adjusted odds ratio [aOR] 0.54, 95% CI 0.31-0.95, p = 0.032 in Adjusted Model 1), while BUN Tertile 2 group showed no statistical significance. There were no significant differences in mortality and sICH among three groups. Subgroup analysis presented a significant interaction between BUN and age for the primary effectiveness outcome (P for interaction = 0.036).
In patients with large ischemic stroke undergoing EVT, an elevated admission BUN (>6.80 mmol/L) was associated with a lower likelihood of favorable functional outcome at 90 days.

PMID:
42845935
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.